Pre-Clinical Studies of Anti-CD123 CAR-T Cells for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

被引：11
|
作者：
Cai, Tianyu [1 ]
Galetto, Roman [2 ]
Gouble, Agnes [2 ]
Smith, Julianne [2 ]
Cavazos, Antonio [1 ]
Konoplev, Sergej [3 ]
Lane, Andrew A. [4 ]
Guzman, Monica L. [5 ]
Kantarjian, Hagop M. [1 ]
Pemmaraju, Naveen [1 ]
Konopleva, Marina [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[2] Cellectis SA, Paris, France
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Weill Cornell Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.4039.4039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4039
引用
收藏
页数：5
相关论文
共 50 条
  • [31] The Effect of CD123 Immunohistochemistry Staining Intensity in Blastic Plasmacytoid Dendritic Cell Neoplasm
    Almakadi, Mohammed
    Borhan, Walaa
    Alrajjal, Ahmed
    Aldhafeeri, Dalal
    Nawaz, Azhar
    Albeihany, Amal
    Almutawa, Abdulmonem
    BLOOD, 2023, 142
  • [32] CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm
    Bole-Richard, Elodie
    Pemmaraju, Naveen
    Cael, Blandine
    Daguindau, Etienne
    Lane, Andrew A.
    CANCERS, 2022, 14 (09)
  • [33] Anti-CD123 CAR T-Cell Therapy for the Treatment of Myelodysplastic Syndrome
    Zhang, Wei
    Stevens, Brett M.
    Budde, Elizabeth
    Forman, Stephen J.
    Schulte, Brian C.
    Jordan, Craig T.
    Purev, Enkhtsetseg
    MOLECULAR THERAPY, 2017, 25 (05) : 268 - 268
  • [34] Anti-CD123 CAR T-Cell Therapy for the Treatment of Myelodysplastic Syndrome
    Zhang, Wei
    Stevens, Brett M.
    Budde, Elizabeth Elizabeth
    Forman, Stephen J.
    Jordan, Craig T.
    Purev, Enkhtsetseg
    BLOOD, 2017, 130
  • [35] Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation
    Jiang, Yi-li
    Li, Qing
    Yuan, Ting
    Jiang, Yan-yu
    Deng, Qi
    ONCOTARGETS AND THERAPY, 2020, 13 : 3425 - 3430
  • [36] Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm
    Economides, Minas P.
    McCue, Deborah
    Lane, Andrew A.
    Pemmaraju, Naveen
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (10) : 941 - 946
  • [37] Treatment of rare cutaneous T‑cell lymphoma and blastic plasmacytoid dendritic cell neoplasm
    Wehkamp U.
    Weichenthal M.
    best practice onkologie, 2017, 12 (7) : 316 - 322
  • [38] Relapse of tagraxofusp treated blastic plasmacytoid dendritic cell neoplasm with loss of CD123 expression
    Rohit Gulati
    Asma Abu-Salah
    Tareq Salous
    Mehdi Nassiri
    Journal of Hematopathology, 2022, 15 : 35 - 39
  • [39] Relapse of tagraxofusp treated blastic plasmacytoid dendritic cell neoplasm with loss of CD123 expression
    Gulati, Rohit
    Abu-Salah, Asma
    Salous, Tareq
    Nassiri, Mehdi
    JOURNAL OF HEMATOPATHOLOGY, 2022, 15 (01) : 35 - 39
  • [40] Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm
    Tandon, A.
    Zhang, Y.
    Sokol, L.
    DRUGS OF TODAY, 2019, 55 (12) : 735 - 742
12345